By Michele Maatouk
Date: Wednesday 31 Dec 2025
(Sharecast News) - Vanda Pharmaceuticals shares rocketed on Wednesday after the US Food and Drug Administration approved its motion sickness drug.
No recent information was found.
| Currency | US Dollars |
| Share Price | $ 6.28 |
| Change Today | $ -0.11 |
| % Change | -1.72 % |
| 52 Week High | $9.52 |
| 52 Week Low | $3.93 |
| Volume | 1,106,098 |
| Shares Issued | 52.38m |
| Market Cap | $328.94m |
| Beta | 0.02 |
| RiskGrade | 297 |
| Strong Buy | 0 |
| Buy | 3 |
| Neutral | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 4 |

| Time | Volume / Share Price |
| 15:59 | 100 @ $6.29 |
| 15:59 | 100 @ $6.29 |
| 15:59 | 100 @ $6.29 |
| 15:59 | 251 @ $6.29 |
| 15:59 | 200 @ $6.29 |
You are here: research